But during the trial Astra brought in a drug-delivery expert from the University of Nottingham who analyzed Andrx's pellets under a microscope with infrared and ultraviolet light and concluded they contain a third layer after all, thus infringing Astra's patents.
Anwar's address in court, coming over a year after the trial began, was part of the defense's final submissions before the delivery of the verdict, which was tentatively set for Aug. 4.